Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Oct 03 2024
Business
Oct 4 2024
4 min read

Press Release Oct 03 2024

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 03, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Alcaftadine Ophthalmic Solution, 0.25% (OTC)".

View Attachment